Effect of teriflunomide versus dimethyl fumarate on cognitive performance in multiple sclerosis patients: real-world data

被引：0
|
作者：
Zohar, D. N. [1 ,2 ]
Achiron, A. [1 ]
机构：
[1] Sheba Med Ctr Hosp, Multiple Sclerosis Ctr, Ramat Gan, Israel
[2] Sheba Med Ctr, Neurol Dept, Ramat Gan, Israel
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1529
引用
收藏
页码：848 / 849
页数：2
相关论文
共 50 条
  • [21] Factors associated with dimethyl fumarate use and treatment patterns among patients with multiple sclerosis in a real-world setting
    Iyer, R.
    Sussman, M.
    Fay, M.
    Buckley, B.
    Lee, A.
    Sarda, S.
    Rana, J.
    Menzin, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E316 - E316
  • [22] The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
    De Masi, Roberto
    Orlando, Stefania
    De Donno, Antonella
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 12
  • [23] Safety and efficacy of dimethyl fumarate in a real-world relapsing-remitting multiple sclerosis population
    Barros, A.
    Sequeira, J.
    Sousa, A.
    Capela, C.
    Pedrosa, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 877 - 878
  • [24] Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study
    Mirabella, M.
    Prosperini, L.
    Lucchini, M.
    Boffa, L.
    Borriello, G.
    Buscarinu, M. C.
    Centonze, D.
    Cortese, A.
    De Fino, C.
    De Giglio, L.
    Elia, G.
    Fantozzi, R.
    Ferraro, E.
    Francia, A.
    Galgani, S.
    Gasperini, C.
    Haggiag, S.
    Landi, D.
    Marfia, G. A.
    Millefiorini, E.
    Monteleone, F.
    Nociti, V.
    Salvetti, M.
    Sgarlata, E.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 615 - 616
  • [25] Multiple sclerosis patients initiating dimethyl fumarate versus fingolimod in the real-world setting have baseline characteristics associated with worse clinical prognosis
    Hersh, C.
    Lei, Y.
    de Moor, C.
    Rudick, R.
    Williams, J. R.
    Kieseier, B.
    Koulinska, I.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 866 - 867
  • [26] Hematological Alterations Related to Treatment with Teriflunomide and Dimethyl Fumarate in Multiple Sclerosis
    Garcia-Estevez, Daniel Apolinar
    NEUROSCI, 2020, 1 (01): : 17 - 23
  • [27] Effect of teriflunomide on cognitive abilities of patients with multiple sclerosis
    Lizhdvoy, V.
    Kotov, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 931 - 931
  • [28] Comparative Effectiveness of Teriflunomide and Dimethyl Fumarate in Patients With Relapsing Forms of MS in the Real-World Teri-RADAR Study
    Zivadinov, Robert
    Burudpakdee, Chakkarin
    Dwyer, Michael G.
    Bergsland, Niels
    Chavin, Jeffrey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cohan, Stanley
    NEUROLOGY, 2018, 90
  • [29] Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
    Belen Pilo de la Fuente
    Julia Sabín
    Victoria Galán
    Israel Thuissard
    Susana Sainz de la Maza
    Lucienne Costa-Frossard
    Mayra Gómez-Moreno
    Judit Díaz-Díaz
    Celia Oreja-Guevara
    Alberto Lozano-Ros
    José M. García-Domínguez
    Laura Borrego
    Lucía Ayuso
    Andy Castro
    Pedro Sánchez
    Virginia Meca-Lallana
    Carmen Muñoz
    Ignacio Casanova
    Carlos López de Silanes
    Hugo Martín
    Elena Rodríguez-García
    Cristina Andreu-Vázquez
    Rosario Blasco
    Juan A. García-Merino
    Yolanda Aladro
    CNS Drugs, 2020, 34 : 1275 - 1286
  • [30] Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
    Pilo de la Fuente, Belen
    Sabin, Julia
    Galan, Victoria
    Thuissard, Israel
    Sainz de la Maza, Susana
    Costa-Frossard, Lucienne
    Gomez-Moreno, Mayra
    Diaz-Diaz, Judit
    Oreja-Guevara, Celia
    Lozano-Ros, Alberto
    Garcia-Dominguez, Jose M.
    Borrego, Laura
    Ayuso, Lucia
    Castro, Andy
    Sanchez, Pedro
    Meca-Lallana, Virginia
    Munoz, Carmen
    Casanova, Ignacio
    Lopez de Silanes, Carlos
    Martin, Hugo
    Rodriguez-Garcia, Elena
    Andreu-Vazquez, Cristina
    Blasco, Rosario
    Garcia-Merino, Juan A.
    Aladro, Yolanda
    CNS DRUGS, 2020, 34 (12) : 1275 - 1286
12345